Investigational. In clinical development, not approved. Material sold as a research chemical is not the trial drug. Educational only — not medical advice.
What it is
Tesofensine is a small-molecule serotonin-noradrenaline-dopamine reuptake inhibitor (not a peptide) studied for obesity.
Proposed mechanism
By raising three neurotransmitters, it suppresses appetite centrally.1 As a CNS stimulant-type mechanism, cardiovascular and psychiatric effects are the key safety questions.
State of the evidence
Phase 2 showed notable weight loss; not FDA-approved.
For educational and research purposes only. This content is not medical advice. Compounds referenced are research use only and not intended to diagnose, treat, cure, or prevent any disease. Free Peptide University does not sell compounds.